- PR Newswire•4 days agoSmith & Nephew invests in and signs agreement to distribute disruptive Leaf Healthcare pressure injury technology
LONDON, Feb. 22, 2017 /PRNewswire/ -- Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, today announces it has taken a strategic investment and signed a distribution agreement with Leaf Healthcare, a developer of a unique wireless patient monitoring system for pressure ulcer/injury prevention. This agreement supports Smith & Nephew's strategic priority to innovate for value by delivering solutions that help healthcare professionals better improve the life of their patients. "Smith & Nephew is focused on providing not just products to treat conditions, but also supporting customers through technologies designed to support prevention as well as treatment," said Glenn Warner, President U.S., Smith & Nephew.
- American City Business Journals•12 days ago
Medical device company Medtronic Neurovascular made the highest amount of non-research payments out of the more than $127 million in payments received by 25 New York City-area doctors in 2015. Minneapolis-based ...
- Capital Cube•16 days ago
Categories: Yahoo Finance Get free summary analysis Smith & Nephew Plc reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Smith & Nephew Plc – Zimmer Biomet Holdings, Inc., Johnson & Johnson, Edwards Lifesciences Corporation, Boston Scientific Corporation, Stryker Corporation, C. R. Bard, Inc. and CONMED Corporation ... Read more (Read more...)
SNN : Summary for Smith & Nephew SNATS, Inc. - Yahoo Finance
Smith & Nephew plc (SNN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||30.57 - 30.71|
|52 Week Range||26.97 - 35.38|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||17.48|
|Dividend & Yield||0.49 (1.60%)|
|1y Target Est||N/A|